Search


 
Results 11 - 20 of about 41 for "FDA update".

Warning issued on dosing of drug for primary biliary ...

Clinicians should determine baseline liver function before starting patients on obeticholic acid, the FDA said.

October 27, 2017 | ACP Gastroenterology Monthly

... eight years ago. FDA update. Warning issued on dosing of drug for primary biliary cholangitis. Clinicians should determine ...

Automated reprocessors validated for use in specific ...

The FDA had requested validation testing data from all companies that have automated endoscope reprocessors labeled to reprocess endoscopes because ...

Drug cleared to treat moderately to severely active ulcerative ...

It is the first oral medication to be approved for chronic use in this population.

Weight-loss devices linked to patient deaths | ACP ...

In a letter to clinicians, the FDA noted five reports of unanticipated deaths that occurred from 2016 to the present in patients treated with liquid-filled intragastric ...

December 22, 2017 | ACP Gastroenterology Monthly

... induced hepatotoxicity. FDA update. Biosimilar approved for certain cases of breast, metastatic stomach cancer. The drug ...

Drug for chronic idiopathic constipation approved | ACP ...

The oral medication is taken once per day and works in the upper GI tract to stimulate secretion of intestinal fluid, supporting regular bowel function.

March 24, 2017 | ACP Gastroenterology Monthly

... HIV co-infection. FDA update. IBS-D drug should not be prescribed to patients without gallbladders. The FDA suggests that ...

January 26, 2018 | ACP Gastroenterology Monthly

... FDA update. Proton-pump inhibitor recalled. One lot of pantoprazole sodium for injection (40 mg per vial) was recalled in December. ...

Duodenoscopes recalled | ACP Gastroenterology Monthly

The recall of ED-530XT duodenoscopes by Fujifilm includes replacement of the ED-530XT forceps elevator mechanism (including the O-ring seal), ...

Result Page: < Previous  1 2 3 4 5  Next >